Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Portea Medical...

    Portea Medical receives Rs 169 crore approx in Series C funding

    Written by Ruby Khatun Khatun Published On 22 Nov 2017 7:00 AM  |  Updated On 18 Aug 2021 6:35 AM

    Bengaluru: Consumer healthcare brand Portea Medical on Tuesday announced Series C funding of USD 26 million (about Rs 169 crore) led by new investors Sabre Partners and MEMG CDC.


    Portea's existing investors Accel, International Finance Corporation (IFC), a member of the World Bank Group and Qualcomm Ventures also participated in this round.


    "We look forward to further refining the paradigm for consumer-centric healthcare in India with the continued support of our customers, investors, and healthcare industry partners," said MD and CEO Portea Medical, Meena Ganesh.


    "With this funding round, we will add more depth to our services and consolidate our position as a trusted port-of-call for every healthcare need that an individual and his/her family members may have outside of hospital care," added Ganesh.


    Portea operates across four major segments; primary care, chronic disease management, elder care, and post-operative care.


    Services offered by them include physiotherapy, doctor consultations, new mother-and-baby care, specialty pharmacy, nutritional wellness, diabetic care, surgery discovery and teleconsultation.


    The company, however, works with more than 50 leading hospital partners, 15 pharma majors, and leading insurance companies in India.


    "The company has played a key role in establishing the concept of consumer-led healthcare and we look forward to working with them as they continue to transform healthcare services in India beyond the hospital space. We focus a lot on the quality of management teams, the industry and the execution strategy of the team. The Portea team is top decile in all of these," said founder and managing partner, Sabre Partners, Rajiv Maliwal.


    "Our investment in Portea will help the company scale and embed technology to improve efficiency and effectiveness in its delivery. We're providing patient, long-term capital to Portea for it to develop capabilities to reach out to many more customers and offer a comprehensive range of out of hospital care services," said MD, MEMG CDC Ventures Limited, Harinarayan Sharma.

    AccelfundFund raisefund raisingfundingHarinarayan SharmaHealthcareIFCInternational Finance CorporationInvestmentMeena GaneshMEMG CDCporteaPortea MedicalQualcomm VenturesreceivesSabre Partnersseries C fundingWorld Bank Group
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok